- Home
- CPS vs EBS Comparison
CPS vs EBS Comparison
Compare CPS & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPS | EBS |
|---|---|---|
| Founded | 1960 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 631.2M | 595.6M |
| IPO Year | 2005 | 2006 |
Fundamental Metrics
Financial Performance| Metric | CPS | EBS |
|---|---|---|
| Price | $31.10 | $8.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $43.33 | $12.00 |
| AVG Volume (30 Days) | 263.5K | ★ 1.0M |
| Earning Date | 05-18-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 94.87 | ★ 125.83 |
| EPS | N/A | ★ 0.93 |
| Revenue | N/A | ★ $742,900,000.00 |
| Revenue This Year | $4.42 | $29.50 |
| Revenue Next Year | $6.36 | N/A |
| P/E Ratio | ★ N/A | $8.89 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.38 | $4.02 |
| 52 Week High | $47.98 | $14.06 |
Technical Indicators
Market Signals| Indicator | CPS | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 34.87 | 27.98 |
| Support Level | $28.47 | $7.66 |
| Resistance Level | $31.60 | $9.68 |
| Average True Range (ATR) | 1.74 | 0.57 |
| MACD | -1.10 | -0.22 |
| Stochastic Oscillator | 1.74 | 10.00 |
Price Performance
Historical ComparisonAbout CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.